Capra Biosciences, Inc.
Modular biomanufacturing facilities for on-demand production of high-value chemicals
- Sector
- Biotech
- Headquarters
- MANASSAS, VA
- Founded
- 2020
- Latest Form D
- $500K, Oct 2024
- Total capital
- $4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4M
- 3 Form D · last Oct 2024
- 25 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$3.4M
- Private capital raisedForm D · SEC · 1st filing$50K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Andrew MagyarExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Danielle JosephDirectorNamed in SEC Form D filings
- Douglas CameronDirectorNamed in SEC Form D filings
- Elizabeth OnderkoExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Pae WuDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 11- PendingBioreactor System for Valorization of Corn Ethanol and Brewery ByproductsUSPTOApplication 18849743
- PendingCirculating Bioreactor With Bubble TrapUSPTOApplication 19039236
- PendingWireless Sensors For Monitoring And Controlling Circulating BioreactorUSPTOApplication 19039251
Show all 11 patent records
- Bioreactor System for Valorization of Corn Ethanol and Brewery ByproductsJun 19, 2025 · Application 18849743Pending
- Circulating Bioreactor With Bubble TrapMay 29, 2025 · Application 19039236Pending
- Wireless Sensors For Monitoring And Controlling Circulating BioreactorMay 29, 2025 · Application 19039251Pending
- Methods of Isoprenoid Synthesis Using a Genetically Engineered Hydrocarbonoclastic Organism in a Biofilm BioreactorOct 27, 2022 · Application 17722182Pending
- Methods Of Isoprenoid Synthesis Using A Genetically Engineered Hydrocarbonoclastic Organism In A Biofilm BioreactorApplication PCTUS2022025100Pending
- Bioreactor System for the Valorization of Corn Ethanol ByproductsApplication 63326428Pending
- Methods of Isoprenoid Synthesis Using a Genetically Engineered Hydrocarbonoclastic Organism in a Biofilm BioreactorApplication 63175858Pending
- Circulating Biofilm BioreactorApplication 19099267Pending
- Circulating Biofilm BioreactorApplication PCTUS2023071992Pending
- Bioreactor System For Valorization Of Corn Ethanol And Brewery ByproductsApplication PCTUS2023017053Pending
- Circulating biofilm bioreactorApplication 63396634Pending
Related companies, and why
- Dayi Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Rise Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- Faraday BiosciencesSimilar federal contract value in Biotech · null in contracts
- Skylark BioSimilar federal contract value in Biotech · null in contracts
- Lexaria Bioscience Corp.Similar federal contract value in Biotech · null in contracts
- SciSparc Ltd.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .